Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Peter Kelly, Josephine Hegarty, Kyle R Dyer & Aine O Donovan. (2022) Organizational attributes and client engagement in community opiate substitute prescribing services. Drugs: Education, Prevention and Policy 0:0, pages 1-14.
Read now
Read now
Ravindra Rao, Swati Kedia Gupta, Prashanth Swaminathan, Vivek Gupta, Anju Dhawan, Alok Agrawal & Atul Ambekar. (2020) Predictors of long-term retention on opioid agonist treatment with buprenorphine: a 6-year, community-based retrospective cohort study in India. Journal of Substance Use 25:5, pages 489-494.
Read now
Read now
Articles from other publishers (26)
Sonam Prakashini Banka-Cullen, Catherine Comiskey, Peter Kelly, Mary Beth Zeni, Ana Gutierrez & Usha Menon. (2023) Nurse prescribing practices across the globe for medication-assisted treatment of the opioid use disorder (MOUD): a scoping review. Harm Reduction Journal 20:1.
Crossref
Crossref
Richard Healy, John Goodwin & Peter Kelly. (2022) ‘As for dignity and respect…. me bollix’: A human rights-based exploration of service user narratives in Irish methadone maintenance treatment. International Journal of Drug Policy 110, pages 103901.
Crossref
Crossref
Tabitha E Moses, Gary L Rhodes, Emytis Tavakoli, Carl W Christensen, Alireza Amirsadri & Mark K Greenwald. (2022) Predictors of Retention and Drug Use Among Patients With Opioid Use Disorder Transferred to a Specialty “Second Chance” Methadone Program. Substance Abuse: Research and Treatment 16, pages 117822182211383.
Crossref
Crossref
Martin Busch, Charlotte Klein, Alfred Uhl, Hans Haltmayer, Maurice Cabanis, Jean Nicolas Westenberg, Marc Vogel & R. Michael Krausz. (2021) Retention in the Austrian opioid agonist treatment system: a national prospective cohort study. Harm Reduction Journal 18:1.
Crossref
Crossref
Chrianna Bharat, Sarah Larney, Sebastiano Barbieri, Timothy Dobbins, Nicola R. Jones, Matthew Hickman, Natasa Gisev, Robert Ali & Louisa Degenhardt. (2021) The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study. Addiction 116:11, pages 3139-3152.
Crossref
Crossref
Dennis McCartyChristina BougatsosBrian ChanKim A. HoffmanKelsey C. PriestSara GrusingRoger Chou. (2021) Office-Based Methadone Treatment for Opioid Use Disorder and Pharmacy Dispensing: A Scoping Review. American Journal of Psychiatry 178:9, pages 804-817.
Crossref
Crossref
Megan Buresh, Robert Stern & Darius Rastegar. (2021) Treatment of opioid use disorder in primary care. BMJ, pages n784.
Crossref
Crossref
Louise Geddes, Jenny Iversen, Handan Wand & Lisa Maher. (2020) Incidence and factors associated with discontinuation of opioid agonist therapy among people who inject drugs in Australia. Addiction 116:3, pages 525-535.
Crossref
Crossref
Louise Durand, Fiona Boland, Denis O’Driscoll, Kathleen Bennett, Joseph Barry, Eamon Keenan, Tom Fahey & Gráinne Cousins. (2021) Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes. Drug and Alcohol Dependence 219, pages 108466.
Crossref
Crossref
Bin Yu, Junmin Zhou, Yi Gong, Jiayu Han, Peijie Dong, Shifan Yang, Rui Liao, Pujun Guan & Shujuan Yang. (2020) Self-efficacy Mediates Perceived Benefits and Barriers of Adherence of Heroin-dependent Patients to Methadone for Addiction Treatment: A Health Belief Model Study. Journal of Addiction Medicine 14:4, pages e110-e117.
Crossref
Crossref
Aisling Máire O’Connor, Gráinne Cousins, Louise Durand, Joe Barry & Fiona Boland. (2020) Retention of patients in opioid substitution treatment: A systematic review. PLOS ONE 15:5, pages e0232086.
Crossref
Crossref
Ide Delargy, Des Crowley & Marie Claire Van Hout. (2019) Twenty years of the methadone treatment protocol in Ireland: reflections on the role of general practice. Harm Reduction Journal 16:1.
Crossref
Crossref
Xiaoyan Fan, Xiao Zhang, Huifang Xu, Fan Yang, Joseph T.F. Lau, Chun Hao, Jinghua Li, Yuteng Zhao, Yuantao Hao & Jing Gu. (2019) Effectiveness of a Psycho-Social Intervention Aimed at Reducing Attrition at Methadone Maintenance Treatment Clinics: A Propensity Score Matching Analysis. International Journal of Environmental Research and Public Health 16:22, pages 4337.
Crossref
Crossref
Zeynab Heydari, Mohammad Reza Baneshi, Hamid Sharifi, Maryam Zamanian, Saiedeh Haji-Maghsoudi & Farzaneh Zolala. (2019) Evaluation of the treatment failure ratio in individuals receiving methadone maintenance therapy via the network scale up method. International Journal of Drug Policy 73, pages 36-41.
Crossref
Crossref
An Thi Minh Dao, Huong Thi Thu Nguyen & Long Hoang Nguyen. (2018) Variation Overtime among Patients of the Six Methadone Maintenance Treatment Clinics in Thai Nguyen from 2011 to 2015. BioMed Research International 2018, pages 1-7.
Crossref
Crossref
Michelle Beattie, Gavin Hookway, Michael Perera, Suzy Calder, Carolyn Hunter-Rowe & Hugo van Woerden. (2018) Improving wait time from referral to opiate replacement therapy in a drug recovery service. BMJ Open Quality 7:3, pages e000295.
Crossref
Crossref
J. Klimas, W. Small, K. Ahamad, W. Cullen, A. Mead, L. Rieb, E. Wood & R. McNeil. (2017) Barriers and facilitators to implementing addiction medicine fellowships: a qualitative study with fellows, medical students, residents and preceptors. Addiction Science & Clinical Practice 12:1.
Crossref
Crossref
Pooja Lagisetty, Katarzyna Klasa, Christopher Bush, Michele Heisler, Vineet Chopra & Amy Bohnert. (2017) Primary care models for treating opioid use disorders: What actually works? A systematic review. PLOS ONE 12:10, pages e0186315.
Crossref
Crossref
Cynthia Marie-ClaireClément Jourdaine, Jean-Pierre Lépine, Frank Bellivier, Vanessa BlochFlorence Vorspan. (2017) Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives. Pharmacogenomics 18:14, pages 1359-1372.
Crossref
Crossref
Wan Shakira R. H.Abdullah Sarimah & Bachok Norsa’adah. (2017) Factor Predictive of 1-Year Retention on Methadone Maintenance Therapy Program: A Survival Analysis Study. Addictive Disorders & Their Treatment 16:2, pages 64-69.
Crossref
Crossref
Maryam Khazaee-Pool & Fatemeh Zarei. (2016) Women Opiate Users' perception toward MMT;A Qualitative Study in Iran. Journal of Human, Environment, and Health Promotion 1:4, pages 237-245.
Crossref
Crossref
Mahmood Sheikh Fathollahi, Fateme Torkashvand, Hamid Najmeddin & Mohsen Rezaeian. (2016) Predictors of One-Year Retention in Methadone Maintenance Treatment (MMT) in Iran, Rafsanjan. International Journal of High Risk Behaviors and Addiction 5:3.
Crossref
Crossref
C. D. Darker, J. Ho, G. Kelly, L. Whiston & J. Barry. (2015) Demographic and clinical factors predicting retention in methadone maintenance: results from an Irish cohort. Irish Journal of Medical Science (1971 -) 185:2, pages 433-441.
Crossref
Crossref
Cynthia Marie-Claire, Severine Crettol, Nicolas Cagnard, Vanessa Bloch, Stéphane Mouly, Jean-Louis Laplanche, Frank Bellivier, Jean-Pierre Lepine, Chin Eap & Florence Vorspan. (2016) Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts. Epigenomics 8:2, pages 181-195.
Crossref
Crossref
Paxton Bach, M-J Milloy, Paul Nguyen, John Koehn, Silvia Guillemi, Thomas Kerr & Evan Wood. (2015) Gender differences in access to methadone maintenance therapy in a Canadian setting. Drug and Alcohol Review 34:5, pages 503-507.
Crossref
Crossref
Anne Bukten, Svetlana Skurtveit, Helge Waal & Thomas Clausen. (2014) Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study. Addictive Behaviors 39:10, pages 1504-1509.
Crossref
Crossref